Scientists developed a prototype two-dose vaccine by combining the Receptor Binding Domain antigen, via conjugation to Diphtheria toxoid.
[NPJ Vaccines]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Immunology of Infectious Disease News Intranasal Administration of BReC-CoV-2 COVID-19 Vaccine Protects K18-hACE2 Mice against Lethal SARS-CoV-2...
